Indo-Bangla Pharmaceuticals Limited

DSE:IBP Stock Report

Market Cap: ৳1.6b

Indo-Bangla Pharmaceuticals Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

A. F. M. Huq

Chief executive officer

৳4.9m

Total compensation

CEO salary percentagen/a
CEO tenure10yrs
CEO ownership16.1%
Management average tenureno data
Board average tenure7.9yrs

Recent management updates

Recent updates


CEO

A. F. M. Huq (49 yo)

10yrs

Tenure

৳4,890,000

Compensation

Mr. A. F. M. Anowarul Huq serves as Managing Director and Director at Indo-Bangla Pharmaceuticals Limited since June 18, 2014.


Board Members

NamePositionTenureCompensationOwnership
A. F. M. Huq
MD & Director10yrs৳4.89m16.05%
BDT 255.6m
Md. Iftikhar-Uz-Zaman
Independent Director4.4yrs৳90.00kno data
Md. Rabbani
Nominated Director of Investment Corporation of Bangladesh7.4yrs৳90.00kno data
Hafiza Yeasmin
Chairman10yrs৳90.00k2.11%
BDT 33.6m
Fatima Parvin
Director7.9yrs৳90.00k2.59%
BDT 41.2m

7.9yrs

Average Tenure

49.5yo

Average Age

Experienced Board: IBP's board of directors are considered experienced (7.9 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.